Monaghan Medical Corporation (Monaghan) and Captis today announced their agreement to a second, three-year contract, solidifying a partnership between two industry leaders. The sole-source agreement highlights the value of Monaghan’s patient outcome evidence and gold standard medical devices, with Captis’ commitment to driving process efficiencies and value driven healthcare spending. The agreement enables Monaghan to provide Captis members with devices in two categories

Indigenous Pact, a leader in creating health equity for American Indians and Alaska Natives (AI/AN), and DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, today announced a partnership to utilize DELFI's FirstLook Lung to increase lung cancer screening and early detection in Tribal communities throughout the State of Washington. The Biden Cancer Moonshot recently highlighted the Indigenous Pact and DELFI Diag

Sonex Health, Inc. and The Institute of Advanced Ultrasound Guided Procedures announced today that ECRI completed a Clinical Evidence Assessment of its UltraGuideCTR™, with an Evidence Bar rating of "Favorable." The ECRI Evidence Bar is a visualization of the organization's judgment about the balance of benefits and harms of technology after assessing the available published clinical evidence in light of key outcomes and comparisons of interest. ECRI's Clinical Evidenc

Freudenberg Medical, a global contract design and manufacturing (CDMO) partner to the medical device and biopharma industry with facilities in key industry hubs across the Americas, Europe and Asia, announced plans to further expand its drug device combination products business. The company is investing more than 50 million USD in a new Hemoteq AG production facility in Aachen, Germany, one of the most important life science hotspots in Europe. Through the acquisition of Hemoteq in

Retrieve Medical Holdings, is proud to announce the granting of a new patent that revolutionizes the management of problem lists within electronic health records (EHR) systems. This patent introduces a novel approach to reorienting problem lists with hierarchical structures, which can be assigned to a designated manager and provides enhanced control and visibility over the problem list, allowing managers to regulate who can enter and modify problems. A problem list is a document tha

Today, Danish MedTech company, °MEQU announces 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) of the °M Warmer System - a portable blood & IV fluid warmer system for military and civilian use. “We are proud to receive the FDA clearance, which is a major milestone for our company and the result of more than 10 years of product development. With the clearance the road is paved for a strong presence in the U.S. market, and we are honored

Pradeep K. Yadav MD, Director of Structural Interventions, Piedmont Heart Institute, Atlanta presented the initial experience with the MiRus Siegel™ 8-Fr aortic transcatheter heart valve (THV) at the New York Valves conference. Five sequential patients with severe, symptomatic aortic stenosis (AS) were treated at the Instituto Nacional Del Torax in Santiago, Chile by Drs. C. Dauvergne, J. Sandoval and P. Yadav. Three patients had bicuspid aortic valves and two were tri-leaflet

The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding (MoU) with AstraZeneca during BIO International Convention 2024 to establish a world-class Rare Diseases Centre of Excellence (CoE) in Abu Dhabi. Leveraging Abu Dhabi's advanced healthcare infrastructure and AstraZeneca's global expertise and experience in rare diseases management, the two entities will spearhead innovation to improve the lives

Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared a labeling revision for da Vinci X and Xi specific to radical prostatectomy. This clearance was based on real-world evidence (RWE) collected from 2007 to 2014 that demonstrates overall five- to 10-year survival following robotic-assisted radical prostatectomy is similar to non-robotic radical prostatectomy.

Keragon, an AI-powered HIPAA-compliant automation platform for healthcare, is officially launching out of stealth. It is the first no-code workflow automation platform designed specifically for the US healthcare industry. Currently, it is used by practices and clinics, fast-growing digital health startups, all the way up to hospitals & NASDAQ-listed companies, across the 50 states. The platform enables instant integration of various popular software used by healthcare practition